HomeComparePBBIF vs O

PBBIF vs O: Dividend Comparison 2026

PBBIF yields 0.50% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 O wins by $13.9K in total portfolio value
10 years
PBBIF
PBBIF
● Live price
0.50%
Share price
$24.00
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$51.65
Full PBBIF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — PBBIF vs O

📍 O pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBBIFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBBIF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBBIF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBBIF
Annual income on $10K today (after 15% tax)
$42.50/yr
After 10yr DRIP, annual income (after tax)
$43.90/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, O beats the other by $4,293.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBBIF + O for your $10,000?

PBBIF: 50%O: 50%
100% O50/50100% PBBIF
Portfolio after 10yr
$27.3K
Annual income
$2,577.20/yr
Blended yield
9.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

PBBIF
No analyst data
Altman Z
1.8
Piotroski
6/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBBIF buys
0
O buys
0
No recent congressional trades found for PBBIF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBBIFO
Forward yield0.50%5.28%
Annual dividend / share$0.12$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$20.4K$34.2K
Annual income after 10y$51.65$5,102.74
Total dividends collected$509.00$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: PBBIF vs O ($10,000, DRIP)

YearPBBIF PortfolioPBBIF Income/yrO PortfolioO Income/yrGap
1← crossover$10,750$50.00$10,818$608.16$68.00O
2$11,553$50.23$11,787$741.68$234.00O
3$12,412$50.45$12,946$911.00$534.00O
4$13,331$50.66$14,345$1,127.94$1.0KO
5$14,315$50.85$16,056$1,409.05$1.7KO
6$15,369$51.03$18,171$1,777.83$2.8KO
7$16,496$51.20$20,820$2,268.21$4.3KO
8$17,702$51.36$24,188$2,929.90$6.5KO
9$18,992$51.51$28,533$3,837.11$9.5KO
10$20,373$51.65$34,235$5,102.74$13.9KO

PBBIF vs O: Complete Analysis 2026

PBBIFStock

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.

Full PBBIF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this PBBIF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBBIF vs SCHDPBBIF vs JEPIPBBIF vs KOPBBIF vs MAINPBBIF vs STAGPBBIF vs ADCPBBIF vs NNNPBBIF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.